A pan-tumor-siRNA aptamer chimera to block nonsense-mediated mRNA decay inflames and suppresses tumor progression

Immune-checkpoint blockade (ICB) therapy has changed the clinical outcome of many types of aggressive tumors, but there still remain many cancer patients that do not Salt Lamps respond to these treatments.There is an unmet need to develop a feasible clinical therapeutic platform to increase the rate of response to ICB.Here we use a previously descr

read more